BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16945149)

  • 1. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
    Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
    BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation.
    Shi J; Shaw CL; Du Plessis D; Richardson AM; Bailey KL; Julien C; Stopford C; Thompson J; Varma A; Craufurd D; Tian J; Pickering-Brown S; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2005 Nov; 110(5):501-12. PubMed ID: 16222525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases.
    Mackenzie IR; Feldman H
    Acta Neuropathol; 2003 Jun; 105(6):543-8. PubMed ID: 12734660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyglutamine diseases: a pathologic view].
    Yamada M
    Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene.
    Mackenzie IR; Baker M; Pickering-Brown S; Hsiung GY; Lindholm C; Dwosh E; Gass J; Cannon A; Rademakers R; Hutton M; Feldman HH
    Brain; 2006 Nov; 129(Pt 11):3081-90. PubMed ID: 17071926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUS pathology in basophilic inclusion body disease.
    Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
    Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases.
    Mackenzie IR; Feldman H
    Dement Geriatr Cogn Disord; 2004; 17(4):333-6. PubMed ID: 15178948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
    Hayashi M; Kobayashi K; Furuta H
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein].
    Nakamura K
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontotemporal lobar degeneration: clinical and pathological relationships.
    Snowden J; Neary D; Mann D
    Acta Neuropathol; 2007 Jul; 114(1):31-8. PubMed ID: 17569065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17.
    Mackenzie IR; Baker M; West G; Woulfe J; Qadi N; Gass J; Cannon A; Adamson J; Feldman H; Lindholm C; Melquist S; Pettman R; Sadovnick AD; Dwosh E; Whiteheart SW; Hutton M; Pickering-Brown SM
    Brain; 2006 Apr; 129(Pt 4):853-67. PubMed ID: 16401619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.
    Pirici D; Vandenberghe R; Rademakers R; Dermaut B; Cruts M; Vennekens K; Cuijt I; Lübke U; Ceuterick C; Martin JJ; Van Broeckhoven C; Kumar-Singh S
    J Neuropathol Exp Neurol; 2006 Mar; 65(3):289-301. PubMed ID: 16651890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration without lobar atrophy.
    Josephs KA; Whitwell JL; Jack CR; Parisi JE; Dickson DW
    Arch Neurol; 2006 Nov; 63(11):1632-8. PubMed ID: 17101834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease.
    Katsuse O; Dickson DW
    Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1():S37-43. PubMed ID: 16317257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct genetic forms of frontotemporal dementia.
    Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
    Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontotemporal lobar degeneration: a descriptive study of 42 patients].
    Reñé R; Campdelacreu J; Escrig A; Gascón-Bayarri J; Hernández-Pardo M; Jaumà S; Rubio F
    Neurologia; 2008 Oct; 23(8):511-7. PubMed ID: 18802798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.